Catamaran Bio is a newly-formed biotechnology company funded by SV Health Investors. Our mission is to harness the power of our innovative TAILWIND™ Platform to develop safe and effective, off-the-shelf, allogeneic immune cell therapies for the treatment of patients with cancer and immune disorders.
- Vipin Suri Chief Scientific Officer
- Celeste Richardson SVP, Research
- Bharat Reddy Head of Business Development
- Mark Boshar Chief Operating Officer